Forward P/S Multiple: Orthofix (OFIX)

Orthofix Medical Inc. - graphic logo of issuer OFIX

Steady demand for niche spinal and joint equipment supports the business of Orthofix Medical Inc. (OFIX). The GURU.Markets portal provides this chart, where the forward P/S parameter clearly visualizes the asset's future valuation, and the value 0.30 becomes the new metric value. The issuer combines metal fixators with biologics, implementing innovative materials to accelerate bone tissue fusion.

orthofix.com - OFIX Market Cap to Projected Revenue (period 07/04/2022 - 11/13/2026)

Summary analytical data breakdowns for Orthofix Corp (OFIX)

- market price and analyst price targets:
Price Chart Orthofix|OFIX - Consensus Target
- company stock exchange capitalization indicators:
Market Capitalization Orthofix Corp|OFIX - Total Enterprise Value
- issuer book value statistics:
Book Value per Share Orthofix|OFIX - Accounting Capitalization|Market Capitalization to Book Value Ratio orthofix.com|OFIX - Company Total Asset Base
- debt and liquidity data:
Total Debt to Capital Orthofix Medical Inc.|OFIX - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Orthofix Medical Inc.|OFIX - Company Aggregate Debts|Debt to Book Capitalization Ratio Orthofix Corp|OFIX - Company Long-Term Debt|Company Current Liabilities Orthofix|Quick Ratio orthofix.com
- financial results and valuation multiples details:
OFIX - Company Net Income|Expected Profit Orthofix Medical Inc.|OFIX - Market Cap to Net Income Ratio|Projected Price to Earnings Orthofix International|OFIX - PEG Multiple|EV/EBITDA Multiple Orthofix Corp|OFIX - Operating income before deduction of amortization|Earnings per share for the last twelve months Orthofix|OFIX - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months orthofix.com|OFIX - Net earnings per share growth this year|Earnings growth forecast for next year Orthofix Medical Inc.
- sales and revenue indicators:
OFIX - Company Total Revenue|Company Projected Revenue Orthofix|OFIX - Market Cap to Revenue Ratio|Forward Price-to-Revenue Multiple Orthofix Corp
Fundamental company analysis:OFIX (Orthofix)
Product sample of Orthofix Corp

Forward P/S reflects the ratio of current market capitalization to projected revenue, determining the premium paid for future cash flows. For Orthofix Medical Inc. (OFIX), this multiple confirms the value of new minimally invasive systems against the backdrop of an aging population. By analyzing the forward P/S history, an investor can gauge the speed of recovery in market confidence regarding the assets. The stability of this metric testifies to the fundamental resilience of the business within the specialized medical sector.

Who Orthofix Medical Inc. competes with

Price-to-Projected Revenue Ratio Boston Scientific Corporation BSX|EW - Forward Price-to-Revenue Multiple|ResMed Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Insulet Inc.|ZBH: Forward P/S Multiple|Market Cap to Projected Revenue COO|ALGN (Align Technology) - Forward P/S Multiple|Globus Medical Inc (GMED) - Market Cap to Expected Sales Ratio|Forward P/S Multiple TMDX|Forward Price-to-Revenue Multiple Alphatec Corp ATEC|Forward P/S Multiple AORT (Artivion, Inc.)|Forward P/S Multiple enovis.com ENOV|IART - Price-to-Projected Revenue Ratio|ESTA: Price-to-Projected Revenue Ratio|BBNX (Beta Bionics Corp) - Forward Price-to-Revenue Multiple|IRADIMED Inc. - Forward Price to Sales|EMBC (Embecta Corp.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio tandemdiabetes.com TNDM|Price-to-Projected Revenue Ratio Axogen (AXGN)|SI-BONE Inc (SIBN) - Projected Price to Revenue|Bioventus Corp - Forward Price-to-Revenue Multiple|Forward P/S Multiple OrthoPediatrics Corp KIDS|Treace Medical Concepts - Forward P/S Multiple|Market Cap to Expected Sales Ratio blade.com SRTA|Carlsmed (CARL) - Price-to-Projected Revenue Ratio|Future Price to Revenue RXST (RxSight Inc)|Price-to-Projected Revenue Ratio ClearPoint Neuro Inc.|Forward Price-to-Revenue Multiple Stereotaxis Corporation (STXS)|Forward P/S Multiple STIM|SGHT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Orchestra BioMed, Inc. OBIO|ANIK: Market Cap to Projected Revenue|NSPR: Forward Price-to-Revenue Multiple|Jin Medical International - Price to Expected Revenue Ratio|vivani.com (VANI) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Xtant Medical (XTNT)|Price-to-Projected Revenue Ratio NeuroOne Medical Technologies Corporation|MODD: Forward Price to Sales|Forward Price-to-Revenue Multiple MYO (Myomo, Inc)|Price to Expected Revenue Ratio COCH|Forward P/S Multiple VVOS (Vivos Therapeutics)|Forward Price to Sales NVNO|SINT - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Tenon Medical Inc.|LFWD: Forward P/S Multiple|Future Price to Revenue AMIX (Autonomix Medical)|IVF (INVO Fertility Inc) - Forward P/S Multiple|bonebiologics.com (BBLG) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple AXNX (Axonics)|BIOLASE Inc. - Market Cap to Projected Revenue|Dynatronics - Forward Price-to-Revenue Multiple|Forward Price to Sales FNA|INVO - Price-to-Projected Revenue Ratio